These patients had undetectable Tg before ablation and were classified into 30 low-risk patients (<40 years old with no advanced signs of disease) and 64 high-risk patients (>40 years old with late stage or metastatic cancer). This evidence concerns the gene TG and metastatic malignant neoplasm.